GLP-1R activation has a significant effect on glycemic control in patients with T2DM through a variety of mechanisms, including stimulation of insulin secretion, inhibition of glucagon secretion, protection of β-cells from apoptosis, slowing gastric emptying and increasing satiety (Drucker, 2006). This evidence concerns the gene INS and type 2 diabetes mellitus.